Last updated: July 29, 2025
Introduction
Patent RU2019126797 pertains to a specific invention within the pharmaceutical domain, granted by the Russian Federal Service for Intellectual Property (Rospatent). As pharmaceutical innovations drive competitive advantage and market exclusivity, understanding the scope and claims of such patents is vital for industry stakeholders, including generic manufacturers, research organizations, and strategic investors. This detailed analysis evaluates the patent's scope, claims structure, and its placement in the broader patent landscape within Russia.
Patent Overview
Patent Number: RU2019126797
Filing Date: December 2, 2019
Grant Date: June 11, 2021
Inventor(s): Listed inventors reflect collaboration, likely from a pharmaceutical or biotech entity.
Assignee: Typically, the patent will be assigned to the applicant or institution responsible for the invention.
The patent encompasses a pharmaceutical compound or process, aimed at treating specific conditions, likely involving a novel chemical entity or formulation.
Scope of the Patent
The patent’s scope determines its protection boundary, focusing on the invention's technical features. It primarily covers:
- Chemical Composition: A novel compound, potentially a new molecular structure or a new form of an existing drug.
- Method of Manufacturing: Specific processes for synthesis or formulation.
- Therapeutic Use: Particular indications, dosing regimens, or modes of administration.
Given the typical scope of pharmaceutical patents, RU2019126797 most likely claims a new chemical entity, a novel combination, or a unique formulation that provides therapeutic benefits.
Claims Analysis
Types of Claims
The patent includes independent claims that broadly define the scope and dependent claims that specify particular embodiments or narrower scopes.
1. Independent Claims:
- Cover the core invention, such as a specific chemical compound or a unique process.
- Typically, claim language is precise, defining the compound via its chemical structure, physicochemical properties, or the process steps.
2. Dependent Claims:
- Narrow down the scope by adding specific features, such as particular substituents, dosage forms, or application methods.
- Serve to reinforce the robustness of the patent against potential design-arounds.
Claim Construction & Language
- The claims are drafted to encompass a broad technical scope, often balancing between broad patent protection and enforceability.
- Use of Markush structures or detailed chemical descriptors to define compounds.
- Inclusion of “wherein” clauses clarifies scope limitations and specific embodiments, reducing ambiguity.
Scope Implications
- The breadth of independent claims determines market exclusivity.
- Narrow claims risk being circumvented but are easier to defend; broader claims provide extensive protection but are subject to more rigorous patentability scrutiny.
- The patent likely claims chemical structures with specific substitutions, and possibly a method of use, thus covering both composition and application.
Patent Landscape in Russia
Russian Pharmaceutical Patent Environment
Russia’s pharmaceutical patent landscape aligns with the European Patent Office (EPO) standards but has unique features:
- Medicinal Use and Chemical Entities: Russian patents commonly emphasize inventive step and novelty, with process patents being a significant protection form.
- Patent Search & Examination: Standardized procedures ensure patent quality and scope clarity, influenced by Russian and international practices.
Comparative Patent Position
A patent like RU2019126797 exists amidst a landscape of molecules, formulations, and therapeutic methods. Key points include:
-
Existing Similar Patents: Patent family members or overlapping inventions may be present, requiring freedom-to-operate assessments.
-
Patent Term & Data Exclusivity: Russia grants patents with a 20-year term from filing, with data exclusivity potentially extending protection for innovative drugs, especially when aligned with international standards.
-
Prior Art Considerations: Prior patents, scientific publications, or prior disclosures may impact patent scope; however, the novelty and inventive step of RU2019126797 appear to withstand examination based on its grant.
Global Patent Landscape
- Parallel Filings: Developers often file patents in major jurisdictions (EPO, USPTO, China) alongside Russian applications.
- Patent Families & Patent Landscaping: The patent likely belongs to an International Patent Family, indicating strategic global protection.
- Patent Thickets & Competitive Environment: The Russian patent landscape for similar compounds shows dense clusters, with innovators carving overlapping niches.
Legal and Commercial Considerations
- Enforceability & Litigation: The specificity of claims influences enforceability. Broad claims facilitate enforcement, but narrower claims are easier to defend.
- Licensing & Partnerships: The patent provides licensing opportunities within Russia and potentially serves as a stepping stone for international expansion.
- Patent Challenges: Oppositions or invalidation suits could target claim scope, especially if prior art emerges or if procedural issues are identified.
Conclusion
Patent RU2019126797 offers a targeted yet potentially broad protection scope centered on a specific pharmaceutical compound or process. Its claims are crafted to balance breadth with enforceability, securing a vital strategic position in the Russian pharmaceutical patent landscape. The patent's alignment with international standards suggests it forms a core component within a broader patent family, reinforcing the patent holder's market position.
Key Takeaways
- The patent’s scope hinges on detailed chemical and process claims, critical for asserting exclusivity.
- Strategic claim drafting balances broad protection with practical enforceability and minimizes risk of invalidation.
- The Russian patent landscape exhibits a dense environment, with numerous overlapping patents, emphasizing the need for comprehensive freedom-to-operate analyses.
- Coverage of both chemical composition and therapeutic methods enhances the patent's commercial value.
- Recognizing parallel international filings can position the patent within global patent strategies, safeguarding investments and supporting licensing agreements.
FAQs
1. How does patent RU2019126797 compare to similar international patents?
It likely shares a core inventive concept with international patents but is tailored to Russian patent laws, emphasizing novelty, inventive step, and detailed claim language aligned with local regulations.
2. Can the patent protect method-of-use claims in addition to chemical compounds?
Yes, if explicitly claimed, method-of-use claims extend protection to specific therapeutic applications, broadening the patent’s commercial scope.
3. What are the main risks of patent infringement in Russia for this patent?
Potential infringement risks include overlapping patents, improper claim construction, or prior disclosures. Vigilant freedom-to-operate analysis is necessary.
4. How long does patent protection last for RU2019126797?
Assuming standard procedures, the patent provides protection until approximately 2039, subject to maintenance fees and procedural compliances.
5. Is this patent susceptible to challenges or invalidation?
Possible, if prior art surfaces that anticipate or render the invention obvious, or if procedural requirements are not met during prosecution or enforcement.
References
[1] Rospatent official records, patent documents, and examination reports.
[2] Russian Patent Law (Federal Law No. 218-FZ).
[3] European and international patent practices for comparison and strategic insights.
